241-255 of 931

Redefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy
Deep Breaths: Updates from CHESTRedefining Non-Small Cell Lung Cancer Care: Updates in Targeted and Perioperative Therapy

Clinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment
Deep Breaths: Updates from CHESTClinical Updates in Non-Small Cell Lung Cancer: From Surveillance to Treatment

Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results
Project Oncology®Clinical Stability Post-Tovorafenib in Pediatric Low-Grade Glioma: FIREFLY-1 Results

Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer
Project Oncology®Evaluating PARP and ER Targeting in ER+/HER2– Breast Cancer

From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer
Project Oncology®From Resistance to Response: Evolving Treatment Pathways in HR+ Breast Cancer

Tracking Tumor Resistance in Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast CancerTracking Tumor Resistance in Metastatic Breast Cancer Care
- advertisement

Optimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
AudioAbstractsOptimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows

Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH
Project Oncology®Tracking Lineage Infidelity in Pediatric B-ALL: New Insights From ASH

Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Project Oncology®Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data

Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Project Oncology®Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies

Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Project Oncology®Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity

Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
Project Oncology®Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
- advertisement

Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
Project Oncology®Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD

Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Project Oncology®Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer

Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
Project Oncology®Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases






















































